Literature DB >> 21190269

NMR relaxation and magnetic properties of superparamagnetic nanoworms.

Yves Gossuin1, Sabrina Disch, Quoc L Vuong, Pierre Gillis, Raphaël P Hermann, Ji-Ho Park, Michael J Sailor.   

Abstract

Maghemite particles are used as T₂ contrast agents for magnetic resonance imaging, especially for molecular and cellular imaging. Linear clusters of particles - called nanoworms - were recently developed to enhance the targeting efficiency. In this work, the magnetic and NMR relaxation properties of these nanoworms are studied at multiple magnetic fields. After the usual saturation at 0.5 T, the magnetization of the worms is still increasing, which results in an appreciable increase of the transverse relaxivity at high magnetic fields. The obtained relaxivities are typical of superparamagnetic particles of iron oxide (SPIOs). The transverse relaxation of the worms is clearly more efficient than for the isolated grains, which is confirmed by computer simulations. At high field, the longitudinal relaxation of the worms is less pronounced than for the grains, as expected for SPIOs. The nanoworms thus constitute a promising T₂ agent for cellular and molecular imaging.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190269      PMCID: PMC6589091          DOI: 10.1002/cmmi.387

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  13 in total

1.  On T(2)-shortening by strongly magnetized spheres: a partial refocusing model.

Authors:  Pierre Gillis; Francis Moiny; Rodney A Brooks
Journal:  Magn Reson Med       Date:  2002-02       Impact factor: 4.668

2.  Controlled aggregation of ferritin to modulate MRI relaxivity.

Authors:  Kevin M Bennett; Erik M Shapiro; Christopher H Sotak; Alan P Koretsky
Journal:  Biophys J       Date:  2008-03-07       Impact factor: 4.033

Review 3.  Magnetic resonance relaxation properties of superparamagnetic particles.

Authors:  Yves Gossuin; Pierre Gillis; Aline Hocq; Quoc L Vuong; Alain Roch
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 May-Jun

4.  T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations.

Authors:  Yuri Matsumoto; Alan Jasanoff
Journal:  Magn Reson Imaging       Date:  2008-05-13       Impact factor: 2.546

5.  Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging.

Authors:  Ji-Ho Park; Geoffrey von Maltzahn; Lianglin Zhang; Michael P Schwartz; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Adv Mater       Date:  2008-05-05       Impact factor: 30.849

6.  Controlled aggregation of superparamagnetic iron oxide nanoparticles for the development of molecular magnetic resonance imaging probes.

Authors:  B A Larsen; M A Haag; N J Serkova; K R Shroyer; C R Stoldt
Journal:  Nanotechnology       Date:  2008-05-19       Impact factor: 3.874

7.  Relaxometry and magnetometry of the MR contrast agent MION-46L.

Authors:  J W Bulte; R A Brooks; B M Moskowitz; L H Bryant; J A Frank
Journal:  Magn Reson Med       Date:  1999-08       Impact factor: 4.668

Review 8.  Iron oxide MR contrast agents for molecular and cellular imaging.

Authors:  Jeff W M Bulte; Dara L Kraitchman
Journal:  NMR Biomed       Date:  2004-11       Impact factor: 4.044

Review 9.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Authors:  Y X Wang; S M Hussain; G P Krestin
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

10.  Experimental validation of proton transverse relaxivity models for superparamagnetic nanoparticle MRI contrast agents.

Authors:  Matthew R J Carroll; Robert C Woodward; Michael J House; Wey Yang Teoh; Rose Amal; Tracey L Hanley; Timothy G St Pierre
Journal:  Nanotechnology       Date:  2010-01-22       Impact factor: 3.874

View more
  5 in total

1.  Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI.

Authors:  Jordy K van Zandwijk; Frank F J Simonis; Friso G Heslinga; Elfi I S Hofmeijer; Robert H Geelkerken; Bennie Ten Haken
Journal:  PLoS One       Date:  2021-08-17       Impact factor: 3.240

2.  Imaging metastasis using an integrin-targeting chain-shaped nanoparticle.

Authors:  Pubudu M Peiris; Randall Toy; Elizabeth Doolittle; Jenna Pansky; Aaron Abramowski; Morgan Tam; Peter Vicente; Emily Tran; Elliott Hayden; Andrew Camann; Aaron Mayer; Bernadette O Erokwu; Zachary Berman; David Wilson; Harihara Baskaran; Chris A Flask; Ruth A Keri; Efstathios Karathanasis
Journal:  ACS Nano       Date:  2012-09-24       Impact factor: 15.881

3.  On-command drug release from nanochains inhibits growth of breast tumors.

Authors:  Pubudu M Peiris; Morgan Tam; Peter Vicente; Aaron Abramowski; Randall Toy; Lisa Bauer; Aaron Mayer; Jenna Pansky; Elizabeth Doolittle; Samantha Tucci; Erik Schmidt; Christopher Shoup; Swetha Rao; Kaitlyn Murray; Ramamurthy Gopalakrishnan; Ruth A Keri; James P Basilion; Mark A Griswold; Efstathios Karathanasis
Journal:  Pharm Res       Date:  2013-08-09       Impact factor: 4.200

4.  Assembly of linear nano-chains from iron oxide nanospheres with asymmetric surface chemistry.

Authors:  Pubudu M Peiris; Erik Schmidt; Michael Calabrese; Efstathios Karathanasis
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

Review 5.  Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.

Authors:  Morgan E Lorkowski; Prabhani U Atukorale; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Healthc Mater       Date:  2020-11-23       Impact factor: 9.933

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.